65,437 trials
Alcohol Drinking · Alcohol Drinking Related Problems
Primary: Change in Self-reported Alcohol Craving in the Laboratory Sessions — 11.7; 20.1; 15.3; 10.0 units on a scale
Paroxysmal Atrial Fibrillation
Primary: Rate of Primary Safety Events at 1-Month Post-Procedure — 13 primary safety events
Poor Thymic Function · Immunodeficiency · Athymia
Primary: Survival Rate at End of 1 Year — 90.9 percentage of participants
Intestinal Obstruction · Colorectal Cancer · Post-Op Complication
Primary: Change in Number of Participants With Post-operative Infectious and Inflammatory Complications — 43; 47; 25; 17 Participants
Knee Osteoarthritis
Primary: Recruitment — 19; 21 Participants
Immune Thrombocytopenia
Primary: Safety and Tolerability (Adverse Events) — 35; 6; 1; 15 Participants
Seasonal Influenza
Primary: Number of Participants With Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs) — 5620; 7989; 3840; 4433 Participants
COVID-19
Primary: Reach-Accept Testing — 509; 423; 351; 329 Participants
Influenza · Acute Respiratory Infection · Influenza-like Illness
Primary: Number of Laboratory-confirmed Influenza Infections — .22; .14 infections
Friedreich Ataxia
Primary: Change in mFARS (Modified Friedreich's Ataxia Rating Scale) Score — 2.9; 4.9; 7.7; 2.2 units on a scale
Dry Eye Syndromes
Primary: Efficacy of ADX-102 on Ocular Discomfort Using the Ora Calibra® Ocular Discomfort Scale. — -0.81; -0.75; -0.82 units on a scale
Peer Influence
Primary: Preschool Language Screener 5 (PLS-5) - Growth Scale Value — 437.09; 455.38; 459.09; 464.77 score on a scale — p=.84
Alcohol Use Disorder
Primary: Number of Participants With Adverse Events (AEs) — 18; 15 Participants
Intravenous Administration
Primary: Pain Score Based on Wong-Baker Pain Scale During IV Placement With Buzzy Bee or Vapocoolent — 4.54; 5.41; 5.03; 3.84 units on a scale
Cognitive Behavioral Therapy · Autism Spectrum Disorder · Anxiety Disorders
Primary: 7-item Pediatric Anxiety Rating Scale — 11.87 Score on a scale